Research, Accelerated.

  • Twitter - White Circle
  • LinkedIn - White Circle
  • Facebook - White Circle

About hyperCORE International

Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies.  It is an industry leader, providing Phase I-IV clinical trial services with more than 81 active research sites across the globe. It is the second largest clinical research site organization globally.  Its member companies have over 100 years of combined experience and have completed more than 6,000 studies helping to evaluate thousands of new drugs and treatments in more than 15,000,000 patients.  Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.

 

hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup and enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. 

 

hyperCORE and its partner members look to elevate the highly fragmented and inherently inefficient site model – something each member has already done on a singular level will now be achieved on a much larger scale.  By combining their strengths and through further integration, the alliance is sure to turn

some heads. The alliance has more than 80 sites across 2 continents, spanning from Lima, Peru to Calgary, Canada – some 7,800 kilometers.

hyperCORE’s founding partner members are: Benchmark Research of Austin, Texas; Clinical Trials of Texas of San Antonio, Texas; DIEX Recherche of Sherbrooke, Canada; FOMAT Medical Research of Oxnard, CA; IACT Health of Columbus, Georgia; LMC Manna Research of Toronto, Canada; M3-Wake Research of Durham, North Carolina; and Research Centers of America (RCA) of Hollywood, Florida.

Performance, Accelerated.

hyperCORE International accelerates every aspect of the research site process - from feasibility through to study start-up.  Our combined reach, diversity  and experience is unparalleled. 

15,000,000

Total Available

Patients

60,000+

Total Patients

Recruited

Total Therapeutic

Areas

35+

81+

Total Site

Locations

6,000+

Total Trials

Completed

320+

Total Principal

Investigators

Total Countries

5

Total Years of

Experience

100+

Information Sheet

 

hyperCORE International: Officers

Mark Lacy is founder and CEO of Benchmark Research – a growing and dynamic firm with a network of quality investigative research sites throughout the United States. Mr. Lacy’s active participation with the Association of Clinical Research Professionals (ACRP) has encompassed serving as Chair of the Site Manager’s Forum, Chair of the Finance Committee, being elected to the Board of Trustees; and in 2005 being honored as a recipient of the Meritorious Service Award. Mr. Lacy also serves on the Board of Advisors for The Center for Information & Study on Clinical Research Participation (CISCRP), and as a member of the Executive Committee for the PharmaTimes U.S. Clinical Researcher of the Year competition.

 

In 2010, Mr. Lacy was selected by Entrepreneur Magazine as one of the top four “Established Entrepreneurs” for his success in growing Benchmark Research, and was recognized in 2011 by PharmaVoice as one of the 100 most Inspiring People. This entrepreneurial approach has extended into his formation of VaxCorps, a nationally prominent research network focusing on vaccines, of which he is the CEO.  He is also emerging as a leader in real estate development in Texas with office buildings in Austin and ocean front resort properties on the Texas coast.

Prior to founding Benchmark Research, Mr. Lacy earned a B.A. degree from The University of Texas at Austin (Plan II Program, Summa Cum Laude); and held several prominent positions in state and national politics, including service under a Presidential Administration.

Dr. Kingsley received his Bachelor of Science degree from the University of Scranton in 1995 with concentrations in biology, chemistry, history, and cultural anthropology, and his Master of Science degree in 1997 in biochemistry.  His medical degree was received from the Philadelphia College of Osteopathic Medicine in 2001 and his MBA was received from Emory University’s Goizueta Business School in 2011.  

 

Dr. Kingsley has been faculty with the Columbus Regional Health Family Medicine Residency as well as Director of Family Medicine and Urgent Care.  He currently holds faculty appointments with the Mercer School of Medicine and the Philadelphia College of Osteopathic Medicine Georgia.

 

Dr. Kingsley is founder and CEO of IACT Health, a research management organization, and 15 wholly owned and integrated clinical research offices in multiple cities in two states. The family of companies conduct phase Ib through IV research in nearly every medical specialty; inpatient and outpatient; pharmaceutical, biotechnology, and medical device. He has dedicated his career to clinical research since 2006. 

 

Dr. Kingsley is the current COO and Chair of the Board of Directors of hyperCORE International, LLP, “Centers of Research Excellence”.  IACT Health is one of eight companies partnered to form a new super network of highly experienced and awarded clinical research sites called hyperCORE International.  Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.

He is also the past Chair of the Board of Trustees for the Association for Clinical Research Professionals which represents more than 13,000 clinical research professionals internationally.  He is the former Treasurer for ACRP and APCR, Past President of ABSAME, sits on three additional Boards, and participates on numerous other local, national, and international committees. Dr. Kingsley obtained his CPI in 2009 and his FACRP in 2017.

 

He enjoys each day with his wife Christine and four beautiful children.  

Dr. Howard Schwartz

Chief Medical Officer

Dr. Howard Schwartz is the Chief Medical Officer for Research Centers of America and serves as Principal Investigator on Vaccine and Phase 1 trials and as a Sub-Investigator on most other trials. He has been involved with over 1000 trials in multiple therapeutic areas and attributes his success to combining a well-trained research staff with a skilled Investigator and motivated trial participant. Throughout his career, he has always led with integrity and made sure all members of the team are well trained on GCP and study specific requirements.

Dr Schwartz is Board Certified in Internal Medicine and Gastroenterology and practiced in South Florida for over 30 years.  He is now focusing on making RCA the premier research site in South Florida. He has lectured and published extensively on many of the clinical trials in which he has participated.  Additionally, he served as an industry consultant and served on numerous Data Safety Management Boards.

Dr. Schwartz was born in Philadelphia, moved to Florida to attend college and never went home. He is a graduate of the University of Miami Miller School of Medicine where he also completed his Internal Medicine Residency and Gastroenterology Fellowship. He is married with 3 children.  He is an avid sports fan, golfer and boater.